New study examines the combinational effect of traditional and repurposed drugs in the treatment of dementia with Lewy bodies.
Browsing: Dementia with Lewy bodies
A recent study reported deposits of a protein, alpha-synuclein, in the synapses of dementia with Lewy bodies patients. The researchers believe it may be this protein that is responsible for the dementia symptoms and the progression of DLB in the brain.
Using FTIR spectroscopy and chemometirc techniques, researchers were able to successfully diagnose and differentiate between various neurodegenerative diseases including Alzheimer’s disease.
Jay Amin from the University of Southampton discusses his research into dementia with Lewy bodies.
A new technique termed the ‘Lewy Body Composite Risk Score’ which has been developed by researchers at Florida Atlantic University (FL, USA) could be used to diagnose Lewy Body Dementia and Parkinson’s dementia in just three minutes.